Rehab of NAD(P)-Dependent Enzymes with NAD(P)-Based Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|13|1891-1908

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.13, 2011-05, pp. : 1891-1908

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NAD(P) Biosynthesis Enzymes as Potential Targets for Selective Drug Design

By  

Current Medicinal Chemistry, Vol. 16, Iss. 11, 2009-04 ,pp. : 1372-1390

Bentham Science Publishers

Access to resources Recommend Favorite

Classical Inhibitors of NOX NAD(P)H Oxidases Are Not Specific

By  

Current Drug Metabolism, Vol. 9, Iss. 8, 2008-01 ,pp. : 686-696

Bentham Science Publishers

Access to resources Recommend Favorite

NAD+ Metabolism and NAD+-Dependent Enzymes: Promising Therapeutic Targets for Neurological Diseases

By  

Current Drug Targets, Vol. 13, Iss. 2, 2012-02 ,pp. : 222-229

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of NAD+ Dependent Histone Deacetylases (Sirtuins)

By  

Current Pharmaceutical Design, Vol. 14, Iss. 6, 2008-02 ,pp. : 562-573

Bentham Science Publishers

Access to resources Recommend Favorite

NAD+/NADH Metabolism and NAD+-Dependent Enzymes in Cell Death and Ischemic Brain Injury: Current Advances and Therapeutic Implications

By  

Current Medicinal Chemistry, Vol. 22, Iss. 10, 2015-01 ,pp. : 1239-1247

Bentham Science Publishers

Access to resources Recommend Favorite